Comment on huang et al. colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrug-resistant acinetobacter baumannii infection: a meta-analysis. j. clin. med. 2022, 11,

HIGHLIGHTS

  • who: Vered Daitch and collaborators from the (UNIVERSITY) have published the research: Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11,, in the Journal: (JOURNAL) of 21/Nov/2022

SUMMARY

    Received Published: 28 November 2022 Publisher`s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affil- In the recently published meta-analysis titled "Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?